DNA impurities can impact the safety of genetically engineered pharmaceuticals; thus, a specific limit value must be set for them during marketing authorisation. This particularly applies to mRNA vaccines, as large quantities of DNA templates are used for their production. Furthermore, when quantifying the total DNA content in the final product, we must observe that, in addition to the mRNA active ingredient, DNA impurities are also encased in lipid nanoparticles and are therefore difficult t...| MDPI
At least four independent labs around the world claim to have detected excessive levels of plasmid DNA in the mRNA Covid vaccines| news.rebekahbarnett.com.au
The impartiality of the Federal Court is in question in light of allegations that a judge concealed her connections to pharmaceutical giant Pfizer before dismissing a legal challenge over its Covid vaccine.| news.rebekahbarnett.com.au
Reanalysis of the data and anomalies inventoried| openvaet.substack.com
Tallahassee, Fla.— On December 6, 2023, State Surgeon General Dr. Joseph A. Ladapo sent a letter[https://www.floridahealth.gov/about/_documents/12-06-2023-DOH-Letter-to-FDA-RFI-on-COVID-19-Vaccines.pdf?utm_source=floridahealth.gov&utm_medium=referral&utm_campaign=PressRelease&utm_content=Florida's_Future_Budget&url_trace_7f2r5y6=Press_Release_Template_fry_2023_alt.docx] to the United States Food and Drug Administration (FDA) Commissioner Dr. Robert M. Califf and Center for Disease Control a...| www.floridahealth.gov
It also appears that the contamination enters the cell nucleus and integrates with human DNA| news.rebekahbarnett.com.au
Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate? Maryanne Demasi investigates Over the past decades, regulatory agencies have seen large proportions of their budgets funded by the industry they are sworn to regulate. In 1992, the US Congress passed the Prescription Drug User Fee Act (PDUFA), allowing industry to...| The BMJ
